The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study
- PMID: 17190853
- DOI: 10.1182/blood-2006-05-021105.
The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study
Abstract
In order to evaluate the changes within the VWF gene that might contribute to the pathogenesis of type 1 von Willebrand disease (VWD), a large multicenter Canadian study was undertaken. We present data from the sequence analysis of the VWF gene in 123 type 1 VWD index cases and their families. We have identified putative mutations within the VWF gene in 63% (n = 78) of index cases, leaving 37% (n = 45) with no identified changes. These changes comprise 50 different putative mutations: 31 (62%) missense mutations, 8 (16%) changes involving the VWF transcriptional regulatory region, 5 (10%) small deletions/insertions, 5 (10%) splicing consensus sequence mutations, and 1 nonsense mutation. Twenty-one of the index cases had more than one putative VWF mutation identified. We were somewhat more likely to identify putative mutations in cases with lower VWF levels, and the contribution of other factors, such as ABO blood group, seems more important in milder cases. Taken as a whole, our data support a complex spectrum of molecular pathology resulting in type 1 VWD. In more severe cases, genetic changes are common within the VWF gene and are highly penetrant. In milder cases, the genetic determinants are more complex and involve factors outside of the VWF gene.
Similar articles
-
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).Blood. 2007 Jan 1;109(1):112-21. doi: 10.1182/blood-2006-05-020784. Epub 2006 Sep 19. Blood. 2007. PMID: 16985174
-
Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study.J Thromb Haemost. 2024 Nov;22(11):3010-3034. doi: 10.1016/j.jtha.2024.06.026. Epub 2024 Jul 11. J Thromb Haemost. 2024. PMID: 39002731
-
Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.Thromb Haemost. 2012 Oct;108(4):662-71. doi: 10.1160/TH12-02-0089. Epub 2012 Aug 7. Thromb Haemost. 2012. PMID: 22871923
-
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506359 Review.
-
Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.Clin Appl Thromb Hemost. 2006 Jul;12(3):277-95. doi: 10.1177/1076029606291401. Clin Appl Thromb Hemost. 2006. PMID: 16959681 Review.
Cited by
-
The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels.Blood. 2013 Jun 27;121(26):5228-37. doi: 10.1182/blood-2012-10-457507. Epub 2013 Mar 25. Blood. 2013. PMID: 23529928 Free PMC article.
-
De novo mutation and somatic mosaicism of gene mutation in type 2A, 2B and 2M VWD.Thromb J. 2016 Oct 4;14(Suppl 1):36. doi: 10.1186/s12959-016-0092-2. eCollection 2016. Thromb J. 2016. PMID: 27766062 Free PMC article.
-
Evaluation of a semi-automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers.Res Pract Thromb Haemost. 2018 Aug 12;2(4):790-799. doi: 10.1002/rth2.12141. eCollection 2018 Oct. Res Pract Thromb Haemost. 2018. PMID: 30349898 Free PMC article.
-
Common VWF sequence variants associated with higher VWF and FVIII are less frequent in subjects diagnosed with type 1 VWD.Res Pract Thromb Haemost. 2018 Jan 23;2(2):390-398. doi: 10.1002/rth2.12077. eCollection 2018 Apr. Res Pract Thromb Haemost. 2018. PMID: 30046743 Free PMC article.
-
Novel cysteine substitution p.(Cys1084Tyr) causes variable expressivity of qualitative and quantitative VWF defects.Blood Adv. 2022 May 10;6(9):2908-2919. doi: 10.1182/bloodadvances.2021005928. Blood Adv. 2022. PMID: 35020809 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous